In: Toxicological Sciences, 2017, vol. 159, no. 1, p. 266-276
|
In: Bioinformatics, 2016, vol. 32, no. 14, p. 2120-2127
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1755-1758
|
In: Microfluidics and Nanofluidics, 2015, vol. 19, no. 2, p. 351-361
|
In: Phytochemistry Reviews, 2015, vol. 14, no. 2, p. 299-315
|
In: Bioinformatics, 2018, vol. 34, no. 16, p. 2808-2816
|
In: Toxicological Sciences, 2017, vol. 157, no. 1, p. 183-195
|
In: Molecular Medicine, 2020, vol. 26, no. 1, p. 102
Clinical observations and preclinical studies both suggest that Down syndrome (DS) may be associated with significant metabolic and bioenergetic alterations. However, the relevant scientific literature has not yet been systematically reviewed. The aim of the current study was to conduct a meta-analysis of metabolites involved in bioenergetics pathways in DS to conclusively determine the...
|
In: British Journal of Pharmacology, 2020, vol. 177, no. 4, p. 866–883
During angiogenesis, quiescent endothelial cells (ECs) are activated by various stimuli to form new blood vessels from pre‐existing ones in physiological and pathological conditions. Many research groups have shown that hydrogen sulfide (H2S), the newest member of the gasotransmitter family, acts as a proangiogenic factor. To date, very little is known about the regulatory role of...
|
In: Cell Systems, 2019, vol. 9, no. 3, p. 309-320.e8
Proteinaceous inclusions containing alpha-synuclein (α-Syn) have been implicated in neuronal toxicity in Parkinson’s disease, but the pathways that modulate toxicity remain enigmatic. Here, we used a targeted proteomic assay to simultaneously measure 269 pathway activation markers and proteins deregulated by α-Syn expression across a panel of 33 Saccharomyces cerevisiae strains that...
|